Low Testosterone News and Research

RSS
Sleep loss reduces healthy young man's testosterone levels

Sleep loss reduces healthy young man's testosterone levels

Pharmaceutical Executive's Ad Stars, DTC Perspectives recognize Auxilium and Heartbeat work

Pharmaceutical Executive's Ad Stars, DTC Perspectives recognize Auxilium and Heartbeat work

FDA approves Abbott's AndroGel for hypogonadism treatment in men

FDA approves Abbott's AndroGel for hypogonadism treatment in men

Testosterone therapy for prostate cancer needs reevaluation: New study

Testosterone therapy for prostate cancer needs reevaluation: New study

FDA accepts Teva's NDA filing of Bio-T-Gel for male hypogonadism

FDA accepts Teva's NDA filing of Bio-T-Gel for male hypogonadism

Lilly's Axiron testosterone replacement therapy now available in US pharmacies

Lilly's Axiron testosterone replacement therapy now available in US pharmacies

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo fourth quarter total revenues increase 31% to $511 million

Endo fourth quarter total revenues increase 31% to $511 million

Longer life with osteoporosis therapy: Study

Longer life with osteoporosis therapy: Study

Lipocine files new patent applications in support of oral testosterone product for hypogonadism

Lipocine files new patent applications in support of oral testosterone product for hypogonadism

Repros receives IRB approval for Androxal Phase IIb study in secondary hypogonadism

Repros receives IRB approval for Androxal Phase IIb study in secondary hypogonadism

FDA approves Endo's FORTESTA Gel for low testosterone

FDA approves Endo's FORTESTA Gel for low testosterone

Research programs embody the promise of anti-aging medicine.

Research programs embody the promise of anti-aging medicine.

Frisky old men - still keen and active:  Sex study

Frisky old men - still keen and active: Sex study

FDA approves Axiron topical solution CIII for testosterone replacement therapy in men

FDA approves Axiron topical solution CIII for testosterone replacement therapy in men

ESF report: Reduced male fertility may contribute to low birth rates

ESF report: Reduced male fertility may contribute to low birth rates

Testosterone treatment for frailty in older men lacks long term benefits

Testosterone treatment for frailty in older men lacks long term benefits

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

Repros commences randomization in Androxal Phase II study in T2DM men with low testosterone

Repros commences randomization in Androxal Phase II study in T2DM men with low testosterone

Link between low testosterone and heart disease deaths: Study

Link between low testosterone and heart disease deaths: Study